NZ509797A
(en)
*
|
1998-07-10 |
2003-11-28 |
Univ Sydney |
Prophylactic treatments of neovascularisation in macular degeneration using a steroid
|
AU767526B2
(en)
|
1999-04-26 |
2003-11-13 |
Gmp Vision Solutions, Inc. |
Trabeculotomy device and method for treating glaucoma
|
ATE283013T1
(de)
*
|
1999-10-21 |
2004-12-15 |
Alcon Inc |
Medikamentenzuführvorrichtung
|
US7943162B2
(en)
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US20050119737A1
(en)
*
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
AR030345A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes relacionados con angiogenesis
|
WO2002056863A2
(en)
*
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
WO2002053129A1
(en)
*
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
JP2004520900A
(ja)
*
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬剤送達装置の改良製造方法
|
EP1418868B1
(de)
|
2001-04-07 |
2008-03-26 |
Glaukos Corporation |
Glaukom-stent für die glaukom-behandlung
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
AU2002305400A1
(en)
|
2001-05-03 |
2002-11-18 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
JP2004536631A
(ja)
*
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
移植可能な薬物送達デバイスおよびその使用
|
EP1404297B1
(de)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
EP1409065B1
(de)
|
2001-07-23 |
2007-01-17 |
Alcon, Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
RU2311892C2
(ru)
*
|
2001-08-29 |
2007-12-10 |
КАРВАЛХО Рикардо А. П. ДЕ |
Имплантируемая и герметизируемая система для однонаправленной доставки терапевтических препаратов в ткани
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
AU2003236525A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California |
Injection devices and methods for testing implants and for unimpeded target location testing
|
US20070265582A1
(en)
*
|
2002-06-12 |
2007-11-15 |
University Of Southern California |
Injection Devices for Unimpeded Target Location Testing
|
BR0313546A
(pt)
*
|
2002-08-05 |
2005-07-12 |
Alcon Inc |
Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
US20050143363A1
(en)
*
|
2002-09-29 |
2005-06-30 |
Innorx, Inc. |
Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
JP2006518383A
(ja)
*
|
2003-02-20 |
2006-08-10 |
アルコン,インコーポレイテッド |
病的な眼の新脈管形成を処置するための糖質コルチコイド処方物
|
PL378210A1
(pl)
*
|
2003-02-20 |
2006-03-20 |
Alcon, Inc. |
Zastosowanie steroidów do leczenia osób cierpiących z powodu zaburzeń gałki ocznej
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
JP2007500250A
(ja)
*
|
2003-06-13 |
2007-01-11 |
アルコン,インコーポレイテッド |
病的な眼の新脈管形成を処置するための非ステロイド性抗炎症剤の処方物
|
EP1635842A4
(de)
*
|
2003-06-20 |
2007-04-04 |
Alcon Inc |
Behandlung von amd mit einer kombination von inhaltsstoffen
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
ZA200508654B
(en)
*
|
2003-07-10 |
2007-01-31 |
Alcon Inc |
Ophthalmic drug delivery device
|
JP4869930B2
(ja)
|
2003-08-26 |
2012-02-08 |
ヴィスタ サイエンティフィック エルエルシー |
眼科薬物供給装置
|
ES2388138T3
(es)
*
|
2003-08-27 |
2012-10-09 |
Ophthotech Corporation |
Terapia de combinación para tratamiento de trastornos neovasculares oculares
|
AU2004274026A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US7276050B2
(en)
*
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
US9549895B2
(en)
*
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
KR101387456B1
(ko)
|
2005-02-09 |
2014-04-21 |
산텐 세이야꾸 가부시키가이샤 |
질환 또는 상태의 치료를 위한 액체 제제
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
WO2006110487A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
PL1919290T3
(pl)
*
|
2005-07-12 |
2014-06-30 |
Ampio Pharmaceuticals Inc |
Sposoby i produkty do leczenia chorób
|
US20100003297A1
(en)
*
|
2005-08-11 |
2010-01-07 |
Massachusetts Institute Of Technology |
Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues
|
US20070100199A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Lilip Lau |
Apparatus and method of delivering biomaterial to the heart
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
WO2007047626A1
(en)
*
|
2005-10-14 |
2007-04-26 |
Alcon, Inc. |
Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis
|
EP2001438A2
(de)
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Stabile formulierungen sowie verfahren zu ihrer herstellung und verwendung
|
DK2001466T3
(en)
|
2006-03-23 |
2016-02-29 |
Santen Pharmaceutical Co Ltd |
LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
|
KR20110038144A
(ko)
*
|
2006-03-31 |
2011-04-13 |
큐엘티 플러그 딜리버리, 인코포레이티드 |
비루관계에 대한 약물 전달 방법, 구조, 및 조성물
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
JP4829345B2
(ja)
*
|
2006-05-04 |
2011-12-07 |
カフマン、ハーバート |
治療剤を眼球に投与するための方法、装置、およびシステム
|
US7981096B2
(en)
*
|
2006-05-12 |
2011-07-19 |
David Castillejos |
Optic nerve head implant and medication delivery system
|
SG138567A1
(en)
*
|
2006-06-21 |
2008-01-28 |
Johnson & Johnson Vision Care |
Punctal plugs for the delivery of active agents
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
EP2043572B1
(de)
|
2006-06-30 |
2014-12-31 |
Aquesys Inc. |
Vorrichtung für druckablass in einem organ
|
US8506515B2
(en)
|
2006-11-10 |
2013-08-13 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
US20100034808A1
(en)
*
|
2006-11-21 |
2010-02-11 |
Toru Nakazawa |
Compositions and methods for preserving cells of the eye
|
US20080140024A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Yoseph Yaacobi |
Drug delivery device
|
WO2008076544A2
(en)
*
|
2006-12-18 |
2008-06-26 |
Alcon Research, Ltd. |
Devices and methods for ophthalmic drug delivery
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US20100104654A1
(en)
*
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
PL2391419T3
(pl)
|
2009-01-29 |
2019-12-31 |
Forsight Vision4, Inc. |
Dostarczanie leku do tylnego odcinka
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
ES2921527T3
(es)
|
2009-06-03 |
2022-08-29 |
Forsight Vision5 Inc |
Administración de fármaco en segmento anterior
|
DE202010017530U1
(de)
|
2009-06-22 |
2012-03-28 |
Dmi Acquisition Corp. |
Danazolverbindung zur Behandlung von Krankheiten
|
CA2765883A1
(en)
*
|
2009-06-22 |
2010-12-29 |
Dmi Acquisition Corp. |
Methods and products for treatment of diseases
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
JP2013523821A
(ja)
*
|
2010-04-06 |
2013-06-17 |
アラーガン、インコーポレイテッド |
前房内薬剤送達のための徐放性リザーバーインプラント
|
WO2011133964A2
(en)
|
2010-04-23 |
2011-10-27 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
WO2011146483A1
(en)
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
EP3861969A1
(de)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injektorvorrichtung zur arzneimittelabgabe
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
US20120109054A1
(en)
*
|
2010-10-29 |
2012-05-03 |
Vista Scientific Llc |
Devices with an erodible surface for delivering at least one active agent to tissue over a prolonged period of time
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
US10842671B2
(en)
|
2010-11-15 |
2020-11-24 |
Aquesys, Inc. |
Intraocular shunt placement in the suprachoroidal space
|
CA2818612C
(en)
|
2010-11-19 |
2020-12-29 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9107816B2
(en)
*
|
2011-02-04 |
2015-08-18 |
Taris Biomedical Llc |
Implantable device for controlled dissolution and diffusion of low solubility drug
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
US20150005254A1
(en)
|
2011-06-27 |
2015-01-01 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
EP4249059A3
(de)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
US9724357B2
(en)
|
2011-08-15 |
2017-08-08 |
Massachusetts Eye & Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
EP3659495B1
(de)
|
2011-09-13 |
2022-12-14 |
Dose Medical Corporation |
Intraokularer physiologischer sensor
|
WO2013040238A2
(en)
|
2011-09-13 |
2013-03-21 |
Vista Scientific Llc |
Sustained release ocular drug delivery devices and methods of manufacture
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
CA2888805C
(en)
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
US8852136B2
(en)
*
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2708209A1
(de)
*
|
2012-09-13 |
2014-03-19 |
AJL Ophthalmic, S.A. |
Epimakulars Skleraimplantat
|
PT2911623T
(pt)
|
2012-10-26 |
2019-11-21 |
Forsight Vision5 Inc |
Sistema oftálmico para libertação prolongada de fármaco no olho
|
EP2914225B1
(de)
*
|
2012-11-01 |
2021-02-17 |
Poway Retinal Technologies LLC |
Netzhautreparaturvorrichtung
|
KR20150105355A
(ko)
|
2012-12-19 |
2015-09-16 |
앰피오 파마슈티컬스 인코퍼레이티드 |
질병을 치료하기 위한 방법
|
US9745558B2
(en)
|
2013-02-18 |
2017-08-29 |
Vegenics Pty Limited |
VEGFR-3 ligand binding molecules and uses thereof
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
TW201507749A
(zh)
|
2013-03-11 |
2015-03-01 |
Sanofi Aventis Deutschland |
用於藥物輸送裝置之組件
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
EP4302736A3
(de)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmisches implantat zur abgabe von therapeutischen substanzen
|
US10098836B2
(en)
*
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
CN105431204A
(zh)
|
2013-07-12 |
2016-03-23 |
奥普索特克公司 |
用于治疗或预防眼科病的方法
|
DK3066201T3
(en)
|
2013-11-07 |
2018-06-06 |
Editas Medicine Inc |
CRISPR-RELATED PROCEDURES AND COMPOSITIONS WITH LEADING GRADES
|
BR122020011777B1
(pt)
|
2013-11-14 |
2022-01-25 |
AqueSys, Inc |
Dispositivo de inserção para o tratamento de glaucoma
|
EP3089748A4
(de)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Behandlung von neovaskularisierung im auge
|
EP3114227B1
(de)
|
2014-03-05 |
2021-07-21 |
Editas Medicine, Inc. |
Verfahren im zusammenhang mit crispr/cas und verfahren zur behandlung des usher-syndroms und von retinitis pigmentosa
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
EP3553176A1
(de)
|
2014-03-10 |
2019-10-16 |
Editas Medicine, Inc. |
Crispr/cas-assoziierte verfahren und zusammensetzungen zur behandlung von kongenitaler leberscher amaurose 10 (lca10)
|
EP3981876A1
(de)
|
2014-03-26 |
2022-04-13 |
Editas Medicine, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit crispr/cas zur behandlung von sichelzellanämie
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
US10258503B2
(en)
|
2014-07-15 |
2019-04-16 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
EP3283004A4
(de)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Augeneinsatzzusammensetzung aus einem semikristallinen oder kristallinen pharmazeutischen wirkstoff
|
AU2016253150B2
(en)
|
2015-04-24 |
2022-04-21 |
Editas Medicine, Inc. |
Evaluation of Cas9 molecule/guide RNA molecule complexes
|
WO2016187426A1
(en)
|
2015-05-19 |
2016-11-24 |
Amorphex Therapeutics Llc |
A device that delivers a sustained low-dose of a myopia-suppressing drug
|
NZ737997A
(en)
|
2015-06-03 |
2019-03-29 |
Aquesys Inc |
Ab externo intraocular shunt placement
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
CN109312338B
(zh)
|
2015-10-30 |
2022-09-27 |
爱迪塔斯医药公司 |
治疗单纯疱疹病毒的crispr/cas相关方法及组合物
|
CN108430405B
(zh)
|
2015-11-20 |
2021-04-13 |
弗赛特影像4股份有限公司 |
用于缓释药物递送装置的多孔结构
|
EP3433364A1
(de)
|
2016-03-25 |
2019-01-30 |
Editas Medicine, Inc. |
Systeme und verfahren zur behandlung von alpha-1-antitrypsin(a1at)-mangel
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
BR112018074389A2
(pt)
|
2016-06-02 |
2019-03-06 |
Aquesys, Inc. |
envio de fármaco intraocular
|
BR112019001887A2
(pt)
|
2016-08-02 |
2019-07-09 |
Editas Medicine Inc |
composições e métodos para o tratamento de doença associada a cep290
|
CA3032153A1
(en)
|
2016-08-19 |
2018-02-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (serms) confer protection against photoreceptor degeneration
|
EP3532616A1
(de)
|
2016-10-28 |
2019-09-04 |
Editas Medicine, Inc. |
Verfahren im zusammenhang mit crispr/cas und zusammensetzungen zur behandlung des herpes-simplex-virus
|
JP2020514407A
(ja)
|
2017-01-24 |
2020-05-21 |
マクリーゲン, インク.Macregen, Inc. |
アポリポプロテイン模倣物を用いる加齢黄斑変性と他の眼疾患の治療
|
WO2018161035A1
(en)
|
2017-03-03 |
2018-09-07 |
Macregen, Inc. |
Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
WO2018204848A1
(en)
|
2017-05-05 |
2018-11-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Ocular applications of matrix bound vesicles (mbvs)
|
EP3622070A2
(de)
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-geführte nukleasesysteme und -verfahren
|
WO2019018350A1
(en)
|
2017-07-17 |
2019-01-24 |
Keith Roizman |
TOPICAL ADMINISTRATION OF THERAPEUTIC AGENTS COMPRISING CELL PENETRATION PEPTIDES, FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
EP3758736B1
(de)
|
2018-03-02 |
2024-05-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Il-34 zur anwendung in einem verfahren zur behandlung von retinaler entzündung und neurodegeneration
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
KR20210133993A
(ko)
|
2019-02-25 |
2021-11-08 |
에디타스 메디신, 인코포레이티드 |
Rho-연관 상염색체-우성 망막색소변성증(adrp)을 치료하기 위한 crispr/rna-가이드 뉴클레아제-관련 방법 및 조성물
|
EP4090381A1
(de)
|
2020-01-17 |
2022-11-23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
<smallcaps/>? ? crx-? ? ? ? ?gentherapie zur behandlung von autosomalen dominanten retinopathien
|
AU2021300425A1
(en)
|
2020-07-02 |
2023-02-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic compounds for use in treating retinal degeneration
|
WO2022221741A1
(en)
|
2021-04-16 |
2022-10-20 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
CN115737892A
(zh)
*
|
2022-11-21 |
2023-03-07 |
诺莱生物医学科技有限公司 |
搭载修复基质的弹性敷料及其制备方法
|